TrialRadiation oncology (London, England)2022

Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial.

Andrew W See et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.